Catalog preview
CJC-1295 / Ipamorelin
A combined GHRH analog and ghrelin mimetic protocol studied for its potential to support pulsatile growth hormone release.
Item details are being reviewed. Prices and purchase availability are not final.
Find your starting point →Know what you're considering.
Overview
CJC-1295 is a long-acting GHRH analog; ipamorelin is a selective growth hormone secretagogue that mimics ghrelin at the GH-secretagogue receptor. When used together, research suggests they may synergistically support the body's natural pulsatile GH release while having minimal effect on cortisol or prolactin.
Ingredients
CJC-1295 acetate; ipamorelin acetate
Use & directions
Compounded subcutaneous injection administered per the clinician-designed schedule.
Important information.
Side effects
Possible: injection-site reactions, transient headache, increased hunger, water retention, fatigue at the start of therapy. Notify your clinician of persistent or unexpected symptoms.
Safety & precautions
Important Safety Information. Not for individuals with active cancer, uncontrolled diabetes, or known hypersensitivity to either peptide. Use is for adults only, under clinician oversight.
Read the information for the exact product and formulation. Ask your clinician or pharmacist about suitability, interactions and any questions.
Service & renewal
Review the terms attached to the selected offer before continuing.
Understand service terms →Shipping
Handling, collection and delivery depend on the product and fulfillment partner.
View shipping information →Questions
Keep health questions in your secure portal. Support can help with general ordering questions.
Get help →